IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Consonance Capital Management LP

Q4 2021 Holdings

Filed 2022-02-14 | 15 holdings | $11.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Compass Therapeutics Inc(CMPX)COM20454B104$11.2M3,500,00098.7%
Tandem Diabetes Care Inc(TNDM)COM NEW875372203$45.3K300,6640.4%
Globus MED Inc(GMED)CL A379577208$26.9K373,2540.2%
Surrozen IncCOM86889P109$22.4K3,497,5000.2%
Silence Therapeutics PLC(SLN)ADS82686Q101$18.1K758,2530.2%
United Therapeutics Corp del(UTHR)COM91307C102$12.9K59,8380.1%
Research Alliance Corp IICOM CL A760873109$2.9K300,0000.0%
Jiya Acquisition CorpCOM CL A47760M102$2.9K300,0000.0%
Medicus Sciences AcquisitionCL A SHSG5960S108$2.9K300,0000.0%
Arya Sciences Acquisitn CorpCLASS A ORD SHSG31658100$2.9K300,0000.0%
Panacea Acquisition Corp IICL A SHSG6882C106$1.9K200,0000.0%
Helix Acquisition CorpCOM CL AG4444C102$1.5K150,0000.0%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$1.3K1,165,8320.0%
Caremax Inc*W EXP 06/08/20214171W111$6445,9600.0%
Medicus Sciences Acquisition*W EXP 02/12/202G5960S124$2433,3310.0%